F-Star Therapeutics is a startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
F-Star Therapeutics is a company headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
F-Star Therapeutics is a clinical-stage biopharmaceutical company focused on developing tetravalent bispecific antibodies for cancer and serious illnesses, with a pipeline including FS118, FS120, FS222, and SB 11285 targeting various immune evasion pathways.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.